MedTrace Logo

NOGO for an Overactive Bladder

NCT04357223 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2020-11-12

No results posted yet for this study

Summary

This is a double-blind, randomized and placebo-controlled study to evaluate the safety and effectiveness of NoGo, a standardized extract from Angelica archangelica, on overactive bladder

Conditions

Interventions

DRUG

extract from Angelica archangelica leaf

A standardized extract from Angelica archangelica leaf. Capsule, Twice Daily

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Universidad Politecnica de Madrid

    collaborator OTHER

  • SagaNatura

    lead INDUSTRY

Principal Investigators

  • Marcela Gonzalez-Gross, Ph.D. · INEF- Universidad Politecnica de Madrid

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2021-02-01
Completion
2021-03-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04357223 on ClinicalTrials.gov